Dosentrx Ltd.

6 clinical trials · Sponsor

Record	Firm	Date
Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform (NCT06344416)	Dosentrx Ltd.	2024-03-30
Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication. (NCT06335758)	Dosentrx Ltd.	2024-01-15
Evaluation of the ReX-C System, in Patients Receiving CFTR Modulators for the Treatment of Cystic Fibrosis (CF). (NCT04215796)	Dosentrx Ltd.	2020-05-12
Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics (NCT04091711)	Dosentrx Ltd.	2020-04-21
Evaluation of ReX-C System in Measurement and Improvement of Patients' Adherence. (NCT03424330)	Dosentrx Ltd.	2019-01-09

Every clearance here is in the API, with alerts when new ones post.